A Massively Parallel CRISPR-Based Screening Platform for Modifiers of Neuronal Activity.

Saved in:
Bibliographic Details
Title: A Massively Parallel CRISPR-Based Screening Platform for Modifiers of Neuronal Activity.
Authors: Boggess SC; Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA.; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Gandhi V; Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA.; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Tsai MC; Department of Neuroscience, Genentech, South San Francisco, CA, USA., Marzette E; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Teyssier N; Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA.; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.; Biological and Medical Informatics Graduate Program, University of California, San Francisco, San Francisco, CA, USA., Yu-Ying Chou J; Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA.; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.; City College of San Francisco, San Francisco, CA, USA., Hu X; Department of Functional Genomics, Genentech, South San Francisco, CA, USA., Cramer A; Department of Neuroscience, Genentech, South San Francisco, CA, USA., Yadanar L; Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA.; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Shroff K; Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA.; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.; Neuroscience Graduate Program, University of California, San Francisco, San Francisco, CA, USA.; Medical Scientist Training Program, University of California, San Francisco, San Francisco, CA, USA., Jeong CG; Department of Neuroscience, Genentech, South San Francisco, CA, USA., Eidenschenk C; Department of Functional Genomics, Genentech, South San Francisco, CA, USA., Hanson JE; Department of Neuroscience, Genentech, South San Francisco, CA, USA., Tian R; Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA.; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Kampmann M; Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA.; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, USA.
Source: BioRxiv : the preprint server for biology [bioRxiv] 2025 Feb 10. Date of Electronic Publication: 2025 Feb 10.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2692-8205
DOI:10.1101/2024.02.28.582546